Picture Berlin Partner Top News from HealthCapital Berlin-Brandenburg 650x100px

Person › Details

Rafaèle Tordjman (Jeito Capital S.A.S.)

Tordjman, Rafaèle (Jeito Capital 201806– President + Founder before Sofinnova Partners 2001–2017)

	Organisation	Jeito Capital S.A.S.
	Group	Jeito Capital (Group)
	Former/major organisation	Sofinnova Partners S.A.S.
	Group	Sofinnova (Group)
	Product	venture capital
	Product 2	LIFE SCIENCES

Record changed: 2023-04-15

Picture Twist Bioscience We Do DNA 650x200px 1size

More documents for Rafaèle Tordjman

[1] Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel....
[2] Jeito Capital. (2/22/22). "Press Release: Jeito Capital Co-leads $65 Million Series A Financing in EyeBio". Paris....
[3] Alentis Therapeutics AG. (11/9/21). "Press Release: Alentis Therapeutics Announces Board Appointments". Basel....
[4] Jeito Capital. (9/20/21). "Press Release: Jeito Capital Becomes Key Player in the Financing of Life Sciences in Europe with the Closing of Jeito I at €534 million ($630 million)". Paris....
[5] Jeito Capital. (7/28/21). "Press Release: Jeito Capital’s Dr. Rafaèle Tordjman Appointed to Promote the French Biotech Ecosystem". Paris....
[6] Jeito Capital. (6/15/21). "Press Release: Jeito Capital Becomes Key Investor in Alentis Therapeutics as Part of $67 Million Series B Financing Round". Paris....
[7] Jeito Capital. (5/27/21). "Press Release: Jeito Capital Leads Oversubscribed $92 million Series C Financing Round in Pulmocide". Paris....
[8] Jeito Capital. (1/26/21). "Press Release: First Year-in-Review – Jeito Capital Confirms Strength of Its Investment Model and 2021 Ambitions with more Deals and Significant Capital". Paris....
[9] InnoSkel S.A.S.. (12/14/20). "Press Release: InnoSkel Launches with €20 Million Series A Financing". Nice....
[10] Jeito Capital. (12/14/20). "Press Release: Jeito Capital Leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)